rs786202517
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP2PP3PP5_Very_Strong
The NM_000314.8(PTEN):c.105_106delGGinsAC(p.MetGly35IleArg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
PTEN
NM_000314.8 missense
NM_000314.8 missense
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.42
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM1
In a strand (size 3) in uniprot entity PTEN_HUMAN there are 6 pathogenic changes around while only 0 benign (100%) in NM_000314.8
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), PTEN. . Gene score misZ 3.4883 (greater than the threshold 3.09). Trascript score misZ 4.1129 (greater than threshold 3.09). GenCC has associacion of gene with Lhermitte-Duclos disease, Bannayan-Riley-Ruvalcaba syndrome, Proteus syndrome, macrocephaly-autism syndrome, Cowden syndrome 1, Cowden disease, Proteus-like syndrome, leiomyosarcoma, activated PI3K-delta syndrome, PTEN hamartoma tumor syndrome, glioma susceptibility 2, renal cell carcinoma.
PP3
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
PP5
Variant 10-87894050-GG-AC is Pathogenic according to our data. Variant chr10-87894050-GG-AC is described in ClinVar as [Likely_pathogenic]. Clinvar id is 185863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.105_106delGGinsAC | p.MetGly35IleArg | missense_variant | ENST00000371953.8 | NP_000305.3 | ||
PTEN | NM_001304717.5 | c.624_625delGGinsAC | p.MetGly208IleArg | missense_variant | NP_001291646.4 | |||
PTEN | NM_001304718.2 | c.-601_-600delGGinsAC | 5_prime_UTR_variant | 2/9 | NP_001291647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTEN | ENST00000371953.8 | c.105_106delGGinsAC | p.MetGly35IleArg | missense_variant | 1 | NM_000314.8 | ENSP00000361021.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 27, 2020 | Not observed in large population cohorts (Lek 2016); Observed in individuals referred for multi-gene panel testing (LaDuca 2017); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28152038) - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2014 | The c.105_106delGGinsAC pathogenic mutation , located in coding exon 2 of the PTEN gene, results from deletion of GG and insertion of AC at nucleotide positions 105 and 106, causing the substitution of two highly-conserved amino acids at codons 35 (methionine to isoleucine) and 36 (glycine to arginine). The p.G36R alteration was first described in an individual with classic Cowden syndrome (CS) and shown to result in abolished PTEN activity in vivo (Celebi JT, Exp. Dermatol. 2000 Apr; 9(2):152-6; RodrÃÂguez-Escudero I, Hum. Mol. Genet. 2011 Nov; 20(21):4132-42). Amino acid substitutions impacting the methionine at codon 35 have been reported as pathogenic in CS and Proteus-like syndrome kindreds and also correlated with loss of PTEN activity (Zhou X, Lancet 2001 Jul; 358(9277):210-1; Tan MH, Am. J. Hum. Genet. 2011 Jan; 88(1):42-56; RodrÃÂguez-Escudero I, Hum. Mol. Genet. 2011 Nov; 20(21):4132-42). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6498 samples (12996 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.002% (greater than 51000 alleles tested) in our clinical cohort. Based on the available evidence, c.105_106delGGinsAC is classified as a pathogenic mutation. - |
Glioma susceptibility 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 15, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at